Endoscopic management of sinonasal tumors: a preliminary report

Am J Rhinol. 2005 May-Jun;19(3):307-15.

Abstract

Background: The increased experience with the endoscopic approach to sinonasal inflammatory disease has resulted in the increased use of endoscopes to manage many different sinonasal pathologies.

Methods: A chart review of patients with sinonasal tumors treated with primary endoscopic management, from January, 1993 to November, 2003 was performed.

Results: Forty patients were identified (26 men and 14 women). The mean age was 53.2 years, and the mean follow-up was 31.1 months. For benign tumors, 24 patients were identified with a mean age of 50.7 years, a mean follow-up of 17.5 months, and a recurrence rate of 4.2%. For malignant tumors, 16 patients were identified, with a mean age of 57.3 years, a mean follow-up of 51.5 months, and a recurrence rate of 31.3%. The overall survival rate was 87.5%.

Conclusion: Endoscopic surgical excision of selective sinonasal tumors may be an effective therapeutic modality. In some cases, adjuvant external procedures may be required based on tumor location.

Publication types

  • Evaluation Study

MeSH terms

  • Adenocarcinoma / surgery
  • Adenoma / surgery
  • Adult
  • Aged
  • Aged, 80 and over
  • Angiofibroma / surgery
  • Carcinoma, Adenoid Cystic / surgery
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / surgery
  • Chondrosarcoma / surgery
  • Endoscopy / methods*
  • Esthesioneuroblastoma, Olfactory / surgery
  • Female
  • Follow-Up Studies
  • Hemangiopericytoma / surgery
  • Humans
  • Male
  • Melanoma / surgery
  • Middle Aged
  • Nasal Cavity / surgery
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / therapy
  • Osteoma / surgery
  • Papilloma, Inverted / surgery
  • Paranasal Sinus Neoplasms / mortality
  • Paranasal Sinus Neoplasms / surgery*
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome